SIREN : 451329791
CONNEXION SANTE is a French company founded 22 years ago, specialized in the sector Formation continue d'adultes. Based in LE CHESNAY-ROCQUENCOURT (78150), this company of category PME shows in 2024 a revenue of 995 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2018 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 994 580 € | 1 063 474 € | 932 862 € | 847 989 € | 1 168 446 € | 740 453 € |
| Net income | 360 232 € | 472 079 € | 393 391 € | 394 515 € | 478 713 € | -13 708 € |
| EBITDA | 506 639 € | 605 631 € | 536 907 € | 556 090 € | 703 609 € | 8 144 € |
| Net margin | 36.2% | 44.4% | 42.2% | 46.5% | 41.0% | -1.9% |
In 2024, CONNEXION SANTE achieves revenue of 995 k€. Revenue is growing positively over 6 years (CAGR: +3.8%). Slight decline of -6% vs 2023. After deducting consumption (0 €), gross margin stands at 995 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 507 k€, representing 50.9% of revenue. Warning negative scissor effect: despite revenue change (-6%), EBITDA varies by -16%, reducing margin by 6.0 pts. This reflects costs rising faster than revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 360 k€, i.e. 36.2% of revenue. This profit can be retained or distributed to shareholders.
994 580 €
994 580 €
506 639 €
481 825 €
360 232 €
50.9%
The debt ratio (= Financial debt / Equity x 100) stands at 9%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 79%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 38.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
9.313%
78.887%
38.715%
0.113
53.8%
In 2024, the debt ratio of CONNEXION SANTE (9.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2024, the financial autonomy of CONNEXION SANTE (78.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
In 2024, the repayment capacity of CONNEXION SANTE (0.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 591.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.4x. Danger: operating income does not cover interest charges, unsustainable situation.
591.078
0.448
In 2024, the liquidity ratio of CONNEXION SANTE (591.08) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
In 2024, the interest coverage of CONNEXION SANTE (0.5x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 64 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 0 days. The gap of 64 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Overall, WCR represents 58 days of revenue, i.e. 162 k€ to permanently finance. Over 2016-2024, WCR increased by +217%, requiring additional financing.
161 609 €
64 j
0 j
0 j
58 j
Based on 134 transactions of similar company sales (all years), the value of CONNEXION SANTE is estimated at 867 486 € (range 313 551€ - 2 781 335€). With an EBITDA of 506 639€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 134 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare CONNEXION SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Formation continue d'adultes
The revenue of CONNEXION SANTE in 2024 is 995 k€.
Yes, CONNEXION SANTE generated a net profit of 360 k€ in 2024.
The headquarters of CONNEXION SANTE is located in LE CHESNAY-ROCQUENCOURT (78150), in the department Yvelines.
The tax return of CONNEXION SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
CONNEXION SANTE operates in the sector Formation continue d'adultes (NAF code 85.59A). See the 'Sector positioning' section above to compare the company with its competitors.